Robert Likic (Ivan Krečak, Ivan Krecak)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 46

Top Topics

Pulmonary Embolism

Inferior Vena Cava

Chronic Kidney Disease

Top Venues

Leukemia & lymphoma

Annals of hematology

International journal of laboratory hematology

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Robert Likic, Danijela Lekovic, Isidora Arsenovic, Andrija Bogdanović, Hrvoje Holik, Ivan Zekanovic, Martina Moric Peric, Marko Lucijanic
Systemic Inflammatory Index in Polycythemia Vera and Its Prognostic Implications. Journal of clinical medicine 13 (15) (2024)
Marko Lucijanic, Robert Likic, Robert Likić
Delayed diagnosis of nonspecific symptoms requiring overdiagnosis and overtreatment? Wiener klinische Wochenschrift 136 (7-8) (2024)
Robert Likic, Danijela Lekovic, Isidora Arsenovic, Hrvoje Holik, Ivan Zekanovic, Martina Moric Peric, Marko Lucijanic
The triple A model (age, absolute neutrophil count, absolute lymphocyte count-AAA) predicts survival and thrombosis in polycythemia vera. American journal of hematology 99 (5) (2024)
Igor Aurer, Ozren Jaksic, Sandra Bašić-Kinda, Stefan Mrđenović, Slobodanka Ostojić-Kolonić, Dominik Lozić, Hrvoje Holik, Sabina Novaković-Coha, Petra Berneš, Robert Likic, Martina Morić-Perić, Marino Narančić, Zdravko Mitrović, Toni Valković
Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era-A Study of KroHem, the Croatian Group for Hematologic Diseases. Biomedicines 12 (2) (2024)
Robert Likic, Danijela Lekovic, Isidora Arsenovic, Hrvoje Holik, Ivan Zekanovic, Martina Moric Peric, Marko Lucijanic
The triple A model (age, absolute neutrophil count, absolute lymphocyte count-AAA) predicts survival and thrombosis in polycythemia vera. American journal of hematology 99 (5) (2024)
Marko Lucijanic, Robert Likic, Ena Soric, Anica Sabljic, Davor Galusic, Hrvoje Holik, Vlatka Perisa, Martina Moric Peric, Ivan Zekanovic, Josipa Budimir, Rajko Kusec
Evaluation of Absolute Neutrophil, Lymphocyte and Platelet Count and Their Ratios as Predictors of Thrombotic Risk in Patients with Prefibrotic and Overt Myelofibrosis. Life (Basel, Switzerland) 14 (4) (2024)
Igor Aurer, Ozren Jaksic, Sandra Bašić-Kinda, Stefan Mrđenović, Slobodanka Ostojić-Kolonić, Dominik Lozić, Hrvoje Holik, Sabina Novaković-Coha, Petra Berneš, Robert Likic, Martina Morić-Perić, Marino Narančić, Zdravko Mitrović, Toni Valković
Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era-A Study of KroHem, the Croatian Group for Hematologic Diseases. Biomedicines 12 (2) (2024)
Marko Lucijanic, Robert Likic, Robert Likić
Delayed diagnosis of nonspecific symptoms requiring overdiagnosis and overtreatment? Wiener klinische Wochenschrift (2024)
Marko Lucijanic, Robert Likic, Ena Soric, Anica Sabljic, Davor Galusic, Hrvoje Holik, Vlatka Perisa, Martina Moric Peric, Ivan Zekanovic, Josipa Budimir, Rajko Kusec
Evaluation of Absolute Neutrophil, Lymphocyte and Platelet Count and Their Ratios as Predictors of Thrombotic Risk in Patients with Prefibrotic and Overt Myelofibrosis. Life (Basel, Switzerland) 14 (4) (2024)
Robert Likic, Danijela Lekovic, Isidora Arsenovic, Hrvoje Holik, Ivan Zekanovic, Martina Moric Peric, Marko Lucijanic
The triple A model (age, absolute neutrophil count, absolute lymphocyte count-AAA) predicts survival and thrombosis in polycythemia vera. American journal of hematology 99 (5) (2024)
Robert Likic, Danijela Lekovic, Andrija Bogdanovic, Marko Lucijanic
High red cell mass and high plasma volume are independently associated with thrombotic risk in polycythemia vera. Leukemia & lymphoma (2024)
Robert Likic, Danijela Lekovic, Dragana Grohovac, Anica Sabljic, Hrvoje Holik, Ivan Zekanovic, Martina Moric Peric, Davor Galusic, Vlatka Perisa, Filip Krecak, Marko Skelin, Marko Lucijanic
Glycated hemoglobin (HbA1c) and thrombotic risk in polycythemia vera and essential thrombocythemia. Leukemia & lymphoma 65 (5) (2024)
Robert Likic, Danijela Lekovic, Dragana Grohovac, Anica Sabljic, Hrvoje Holik, Ivan Zekanovic, Martina Moric Peric, Davor Galusic, Vlatka Perisa, Filip Krecak, Marko Skelin, Marko Lucijanic
Glycated hemoglobin (HbA1c) and thrombotic risk in polycythemia vera and essential thrombocythemia. Leukemia & lymphoma 65 (5) (2024)
Robert Likic, Danijela Lekovic, Dragana Grohovac, Anica Sabljic, Hrvoje Holik, Ivan Zekanovic, Martina Moric Peric, Davor Galusic, Vlatka Perisa, Filip Krecak, Marko Skelin, Marko Lucijanic
Glycated hemoglobin (HbA1c) and thrombotic risk in polycythemia vera and essential thrombocythemia. Leukemia & lymphoma (2024)
Marko Lucijanic, Robert Likic, Robert Likić
Delayed diagnosis of nonspecific symptoms requiring overdiagnosis and overtreatment? Wiener klinische Wochenschrift 136 (7-8) (2024)
Robert Likic, Danijela Lekovic, Isidora Arsenovic, Hrvoje Holik, Ivan Zekanovic, Martina Moric Peric, Marko Lucijanic
The triple A model (age, absolute neutrophil count, absolute lymphocyte count-AAA) predicts survival and thrombosis in polycythemia vera. American journal of hematology (2024)
Robert Likic, Danijela Lekovic, Isidora Arsenovic, Andrija Bogdanović, Hrvoje Holik, Ivan Zekanovic, Martina Moric Peric, Marko Lucijanic
Systemic Inflammatory Index in Polycythemia Vera and Its Prognostic Implications. Journal of clinical medicine 13 (15) (2024)
Srdan Verstovsek, Robert Likic, Florian H Heidel, Valerio De Stefano, Kenneth Bryan, Mike W Zuurman, Michael Zaiac, Mara Morelli, Aoife Smyth, Santiago Redondo, Erwan Bigan, Michael Ruhl, Christoph Meier, Magali Beffy, Jean-Jacques Kiladjian
Identifying Patients with Polycythemia Vera at Risk of Thrombosis after Hydroxyurea Initiation: The Polycythemia Vera-Advanced Integrated Models (PV-AIM) Project. Biomedicines 11 (7) (2023)
Robert Likic, Marko Skelin, Srdan Verstovsek
Evaluating ropeginterferon alfa-2b for the treatment of adults with polycythemia vera. Expert review of hematology (2023)
Robert Likic, Marijana Šupe, Ojdana Petričević Krečak
The great mimicker of dural pathology: primary dural diffuse large B-cell lymphoma. Wiener klinische Wochenschrift (2023)
Robert Likic, Ivan Zekanović, Martina Morić Perić, Hrvoje Holik, Božena Coha, Vlatka Periša, Marko Lucijanic
High plateletcrit may be associated with thrombotic risk in polycythemia vera. International journal of laboratory hematology (2023)
Marko Lucijanic, Robert Likic
The Complete Blood Count: Increasing Its Precision and Impact. Annals of internal medicine 176 (8) (2023)
Robert Likic, Srdan Verstovsek, Marko Lucijanic
Optimization of cardiovascular risk factor management in patients with BCR::ABL1 negative chronic myeloproliferative neoplasms, current knowledge, and perspectives. Annals of hematology (2023)
Robert Likic, Marko Lucijanic
Duffy-null erythrocyte phenotype and the risk of thrombotic events in essential thrombocythemia. EJHaem 4 (4) (2023)
Marko Lucijanic, Robert Likic, Ena Soric, Davor Galusic, Hrvoje Holik, Vlatka Perisa, Martina Moric Peric, Ivan Zekanovic, Rajko Kusec
Palpable spleen size is differently prognostic in primary and secondary myelofibrosis. Leukemia & lymphoma (2023)
Robert Likic, Monika Čeko, Karla Nižetić, Eva Čubrić, Mediana Županović, Marko Skelin, Marko Lucijanic
Hematocrit to hemoglobin ratio (HHR) may improve prognostication in patients with pulmonary embolism. Scandinavian journal of clinical and laboratory investigation (2023)
Hrvoje Holik, Marko Lucijanic, Robert Likic
Specific symptom burden in patients with chronic myeloproliferative neoplasms and chronic kidney disease. Annals of hematology (2023)
Robert Likic, Karla Nižetić, Monika Čeko, Marko Skelin, Marko Lucijanić
Higher estimated plasma volume status may be associated with an inferior survival in patients with pulmonary embolism. International journal of laboratory hematology (2022)
Robert Likic, Marko Lucijanic, Srdan Verstovsek
Advances in Risk Stratification and Treatment of Polycythemia Vera and Essential Thrombocythemia. Current hematologic malignancy reports 17 (5) (2022)
Robert Likic, Hrvoje Holik, Martina Morić Perić, Ivan Zekanović, Božena Coha, Marko Lucijanić
Chronic Kidney Disease has a Higher Prevalence in Polycythemia Vera than in Secondary Polycythemia, a Matched Case-Control Analysis. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 39 (4) (2022)
Robert Likic, Hrvoje Holik, Martina Morić Perić, Ivan Zekanović, Božena Coha, Velka Gverić-Krečak, Marko Lucijanić
Serum osmolarity in polycythemia vera and its clinical associations. International journal of laboratory hematology 44 (5) (2022)
Robert Likic, Hrvoje Holik, Božena Coha, Martina Morić Perić, Ivan Zekanović, Marija Valovičić Krečak, Velka Gverić-Krečak, Marko Lucijanić
Low-density lipoprotein (LDL) and the risk of thrombotic events in essential thrombocythemia and polycythemia vera. Annals of hematology 100 (5) (2021)
Robert Likic, Hrvoje Holik, Martina Morić Perić, Ivan Zekanović, Božena Coha, Marija Valovičić Krečak, Velka Gverić-Krečak, Marko Lucijanić
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as prognostic biomarkers in polycythemia vera. International journal of laboratory hematology 44 (4) (2021)
Robert Likic, Ivana Ruščić, Josipa Jović Zlatović, Marijana Šupe, Marija Valovičić Krečak, Velka Gverić-Krečak
Paraneoplastic aortitis in a patient with relapsed multiple myeloma successfully treated with daratumumab, bortezomib and dexamethasone. Annals of hematology 100 (6) (2021)
Robert Likic, Ivan Zekanović, Hrvoje Holik, Martina Morić Perić, Božena Coha, Velka Gverić-Krečak
Estimating plasma volume using the Strauss-derived formula may improve prognostication in polycythemia vera. International journal of laboratory hematology (2021)
Robert Likic, Bojan Gardijan, Jasminka Brkičić, Robert Grubišić-Čabo, Velka Gverić-Krečak
Cryptic brain abscess - do not forget hereditary hemorrhagic teleangiectasia! American journal of hematology 96 (5) (2021)
Marko Lucijanic, Davor Galusic, Robert Likic, Martina Sedinic, Ena Soric, Hrvoje Holik, Vlatka Perisa, Martina Moric Peric, Ivan Zekanovic, Tajana Stoos-Veic, Rajko Kusec
C reactive protein to albumin ratio as prognostic marker in primary and secondary myelofibrosis. Leukemia & lymphoma 61 (12) (2020)
Hrvoje Holik, Robert Likic, Velka Gverić-Krečak, Ivana Vučinić Ljubičić, Božena Coha
Higher red blood cell distribution width might differentiate primary from secondary polycythemia: A pilot study. International journal of laboratory hematology 43 (2) (2020)
Robert Likic, Marko Lucijanic, Velka Gverić-Krečak, Nadira Duraković
Hyperuricemia might promote thrombosis in essential thrombocythemia and polycythemia vera. Leukemia & lymphoma 61 (7) (2020)
Robert Likic, Hrvoje Holik, Morić Perić Martina, Ivan Zekanović, Božena Coha, Velka Gverić-Krečak
Chronic kidney disease could be a risk factor for thrombosis in essential thrombocythemia and polycythemia vera. International journal of hematology 112 (3) (2020)
Marko Lucijanic, Robert Likic
Effect of age and comorbidities on the decline of glomerular filtration rate in chronic myeloid leukemia patients discontinuing tyrosine kinase inhibitors. International journal of hematology 112 (2) (2020)
Robert Likic, Hrvoje Holik, Martina Morić-Perić, Ivan Zekanović, Božena Coha, Velka Gverić-Krečak
The impact of statins on the intensity of phlebotomies in polycythemia vera. Annals of hematology 99 (4) (2020)
Robert Likic, Marijana Šupe, Ivana Ilić, Velka Gverić-Krečak
Behҫet-like syndrome associated with aplastic anemia successfully treated with mycophenolate mofetil. Annals of hematology 100 (9) (2020)
Robert Likic, Velka Gverić-Krečak, Ivana Lapic, Pavle Rončević, Josipa Gulin, Ksenija Fumić, Filip Krečak, Hrvoje Holik, Nadira Duraković
Circulating YKL-40 in Philadelphia-negative myeloproliferative neoplasms. Acta clinica Belgica 76 (1) (2019)
Robert Likic, Marijana Grgic Medic, Velka Gveric-Krecak, Pavle Roncevic, Sandra Bašić Kinda, Jaksa Babel, Radovan Radonic
Coombs-positive refractory acquired thrombotic thrombocytopenic purpura in a patient with chronic myelomonocytic leukemia successfully treated with rituximab. Acta clinica Belgica 75 (5) (2019)
Robert Likic, Velka Gveric-Krecak, Pavle Roncevic, Sandra Basic-Kinda, Josipa Gulin, Ivana Lapic, Ksenija Fumic, Ivana Ilic, Ivana Horvat, Renata Zadro, Hrvoje Holik, Bozena Coha, Nena Peran, Igor Aurer, Nadira Duraković
Serum chitotriosidase: a circulating biomarker in polycythemia vera. Hematology (Amsterdam, Netherlands) 23 (10) (2018)